Investment Firm Bets Big on TNGX Stock With $9.5 Million Purchase, According to Recent SEC Filing [Yahoo! Finance]
Tango Therapeutics, Inc. (TNGX)
Company Research
Source: Yahoo! Finance
Boxer Capital Management, LLC disclosed a buy of 1,104,734 shares of Tango Therapeutics (NASDAQ:TNGX) , with the estimated transaction value at $9.52 million based on average quarterly pricing, according to a February 17, 2026, SEC filing. What Happened According to an SEC filing dated February 17, 2026, Boxer Capital Management, LLC increased its position in Tango Therapeutics by 1,104,734 shares. The estimated transaction value was $9.52 million, based on the average closing price during the fourth quarter of 2025. The fund held 10,876,219 shares at the end of the period, with the position's total value rising by $14.28 million, reflecting both share acquisition and price appreciation. What Else to Know The buy raised the Tango Therapeutics stake to 21.09% of Boxer Capital's 13F reportable AUM as of December 31, 2025 Top holdings after the filing: NASDAQ:TNGX: $96.36 million (21.1% of AUM) NASDAQ:RVMD: $31.86 million (7.0% of AUM) NASDAQ:KOD: $31.76 million (7.0% of
Show less
Read more
Impact Snapshot
Event Time:
TNGX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TNGX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TNGX alerts
High impacting Tango Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
TNGX
News
- Tango Therapeutics (TNGX) Hits All-Time High as Analyst Turns Bullish [Yahoo! Finance]Yahoo! Finance
- Tango Therapeutics (TNGX) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..MarketBeat
- Tango Therapeutics GAAP EPS of -$0.29 beats by $0.03, revenue of $0M misses by $0.5M [Seeking Alpha]Seeking Alpha
- Tango Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business HighlightsGlobeNewswire
- Tango Therapeutics (NASDAQ:TNGX) is now covered by analysts at Mizuho. They set an "outperform" rating and a $19.00 price target on the stock.MarketBeat
TNGX
Earnings
- 3/5/26 - Beat
TNGX
Sec Filings
- 3/5/26 - Form 144
- 3/5/26 - Form S-8
- 3/5/26 - Form 8-K
- TNGX's page on the SEC website